BTCS Inc.

NasdaqCM:BTCS Stock Report

Market Cap: US$148.9m

BTCS Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Charles Allen

Chief executive officer

US$3.0m

Total compensation

CEO salary percentage14.51%
CEO tenure11.8yrs
CEO ownership10.0%
Management average tenureno data
Board average tenure11.1yrs

Recent management updates

Recent updates

BTCS' (NASDAQ:BTCS) Earnings Aren't As Good As They Appear

Nov 20
BTCS' (NASDAQ:BTCS) Earnings Aren't As Good As They Appear

BTCS (NASDAQ:BTCS) Is Making Moderate Use Of Debt

Aug 16
BTCS (NASDAQ:BTCS) Is Making Moderate Use Of Debt

BTCS: The Rise Of The Ethereum Treasury Company?

Jul 10

BTCS' (NASDAQ:BTCS) Problems Go Beyond Weak Profit

Nov 20
BTCS' (NASDAQ:BTCS) Problems Go Beyond Weak Profit

What BTCS Inc.'s (NASDAQ:BTCS) 260% Share Price Gain Is Not Telling You

Nov 16
What BTCS Inc.'s (NASDAQ:BTCS) 260% Share Price Gain Is Not Telling You

BTCS' (NASDAQ:BTCS) Profits May Be Overstating Its True Earnings Potential

Mar 28
BTCS' (NASDAQ:BTCS) Profits May Be Overstating Its True Earnings Potential

At US$1.57, Is It Time To Put BTCS Inc. (NASDAQ:BTCS) On Your Watch List?

Mar 26
At US$1.57, Is It Time To Put BTCS Inc. (NASDAQ:BTCS) On Your Watch List?

Companies Like BTCS (NASDAQ:BTCS) Can Afford To Invest In Growth

Feb 02
Companies Like BTCS (NASDAQ:BTCS) Can Afford To Invest In Growth

BTCS invests in operator of Upstream, a securities exchange built on ether blockchain

Oct 18

BTCS  GAAP EPS of -$0.61 misses by $0.59, revenue of $0.51M misses by $0.09M

Aug 12

We're Keeping An Eye On BTCS' (NASDAQ:BTCS) Cash Burn Rate

Jun 14
We're Keeping An Eye On BTCS' (NASDAQ:BTCS) Cash Burn Rate

BTCS: Best Crypto Stock For Dividend Growth Investors

Jan 27

CEO Compensation Analysis

How has Charles Allen's remuneration changed compared to BTCS's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

US$54m

Jun 30 2025n/an/a

-US$20m

Mar 31 2025n/an/a

-US$31m

Dec 31 2024US$3mUS$430k

-US$1m

Sep 30 2024n/an/a

US$4m

Jun 30 2024n/an/a

US$10m

Mar 31 2024n/an/a

US$15m

Dec 31 2023US$804kUS$411k

US$8m

Sep 30 2023n/an/a

-US$893k

Jun 30 2023n/an/a

US$1m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$3mUS$369k

-US$16m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$10mUS$377k

-US$16m

Sep 30 2021n/an/a

-US$21m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$1mUS$361k

-US$3m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$601kUS$345k

-US$2m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

-US$1m

Mar 31 2019n/an/a

-US$1m

Dec 31 2018US$256kUS$256k

-US$832k

Compensation vs Market: Charles's total compensation ($USD2.96M) is above average for companies of similar size in the US market ($USD586.50K).

Compensation vs Earnings: Charles's compensation has increased by more than 20% in the past year.

CEO

Charles Allen (50 yo)

11.8yrs
Tenure
US$2,963,847
Compensation

Mr. Charles W. Allen is Independent Director of 60 Degrees Pharmaceuticals, Inc. from July 12, 2023. He served as Director at Innovation1 Biotech Inc. since December 02, 2022 and served as its Treasurer an...

Board Members

NamePositionTenureCompensationOwnership
Charles Allen
Chairman & CEO11.8yrsUS$2.96m9.97%
$ 14.9m
Michal Handerhan
Co-Founder & Director11.8yrsUS$1.44m2.79%
$ 4.2m
Ashley DeSimone
Independent Director1.6yrsUS$56.93k0.10%
$ 155.1k
William O'Brien
Member of Advisory Board11.1yrsno datano data
David Bailey
Member of Advisory Board11.1yrsno datano data
Patrick Cines
Member of Advisory Board11.1yrsno datano data
Bruce Fenton
Member of Advisory Board11.1yrsno datano data
Jeremy Gardner
Member of Advisory Board11.1yrsno datano data
Jason King
Member of Advisory Board11.1yrsno datano data
Jonathan Silverman
Member of Advisory Board11.1yrsno datano data
Changpeng Zhao
Member of Advisory Board11.1yrsno datano data
Melanie Pump
Independent Director3.1yrsUS$85.00k0.13%
$ 192.1k
11.1yrs
Average Tenure
48yo
Average Age

Experienced Board: BTCS's board of directors are seasoned and experienced ( 11.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/30 23:03
End of Day Share Price 2025/11/28 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BTCS Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin DedeH.C. Wainwright & Co.